We are a bio-pharmaceutical company focused on the development of novel antibiotics to combat the evolving threat of bacterial infections in humans and animals.
MerLion Pharmaceuticals is located in Berlin-Buch, Germany and manages the non-clinical and clinical development as well as active pharmaceutical ingredient and drug product development and manufacturing.
Our pipeline includes the antibiotics finafloxacin and friulimicin.
MerLion Pharmaceuticals is located in Berlin-Buch, Germany and manages the non-clinical and clinical development as well as active pharmaceutical ingredient and drug product development and manufacturing.
Our pipeline includes the antibiotics finafloxacin and friulimicin.
Location: Germany, Berlin
Employees: 11-50
Founded date: 2000
Investors 2
| Date | Name | Website |
| - | Heidelberg... | heidelberg... |
| - | VI Partner... | vipartners... |
Mentions in press and media 2
| Date | Title | Description |
| 18.05.2021 | Press Release : MerLion Pharmaceuticals Completes Growth Financing Round | - Proceeds will be used to facilitate MerLion`s production and market launch of Xtoro(TM) Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics fo... |
| 15.05.2003 | British Biotech and MerLion Pharmaceuticals establish collaboration | British Biotech and MerLion Pharmaceuticals establish collaboration 15-05-2003 Cambridge, UK, and Singapore. .. British Biotech plc and MerLion Pharmaceuticals Pte Ltd., a Singapore-based drug discovery company, have signed a two-year resea... |